Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016) today in Barcelona. Today’s program included teaching courses, scientific presentations, an official welcome from the ESOC President Professor Kennedy Lees and from Professor Angel Chamorro, and presentations from major clinical trials.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take-homes from our International Development Officer, Sarah Belson.
The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.
Two new research studies were published today, supporting the use of thrombectomy (mechanical retrieval of clots in the brain) for the treatment of large ischaemic strokes.
Two more studies support (thrombectomy) mechanical clot retrieval for stroke.
Cognitive impairments after stroke can affect people’s confidence and mood as well as their ability to recover. PRECiS stands for ‘Patient-Reported Evaluation of Cognitive State’.
A new study published in the journal, Clinical Rehabilitation, suggests that a screening tool may help detect post-stroke anxiety in older people. The research was led by Professor Ian Kneebone (University of Technology Sydney, Australia), and was funded by the Stroke Association.
UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.